In cancer, including hematological malignancies such as B-ALL, overexpression of ectonucleotidases, mainly CD39 and CD73, has been associated with increased cell resistance and proliferation as well as modulation of immune responses into tolerance [43]. Here, ENTPD1 is linked to hematologic disorder.